A detailed history of Redpoint Investment Management Pty LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 38,632 shares of ABBV stock, worth $7.35 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
38,632
Previous 44,031 12.26%
Holding current value
$7.35 Million
Previous $6.74 Million 23.12%
% of portfolio
0.76%
Previous 0.8%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 14, 2022

SELL
$134.21 - $153.93 $724,599 - $831,068
-5,399 Reduced 12.26%
38,632 $5.19 Million
Q1 2022

Apr 13, 2022

SELL
$131.98 - $163.75 $97,005 - $120,356
-735 Reduced 1.64%
44,031 $7.14 Million
Q4 2021

Jan 19, 2022

SELL
$107.43 - $135.93 $42,649 - $53,964
-397 Reduced 0.88%
44,766 $6.06 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $159,068 - $180,566
-1,495 Reduced 3.2%
45,163 $4.87 Million
Q1 2021

Apr 13, 2021

BUY
$102.3 - $112.62 $4.77 Million - $5.25 Million
46,658 New
46,658 $5.05 Million
Q4 2020

Jan 13, 2021

SELL
$80.49 - $108.67 $3.45 Million - $4.65 Million
-42,834 Closed
0 $0
Q3 2020

Oct 09, 2020

SELL
$85.91 - $100.83 $5.84 Million - $6.86 Million
-68,022 Reduced 61.36%
42,834 $3.75 Million
Q2 2020

Jul 17, 2020

BUY
$73.37 - $98.18 $552,109 - $738,804
7,525 Added 7.28%
110,856 $10.9 Million
Q4 2019

Feb 25, 2020

SELL
$72.13 - $90.25 $62,320 - $77,976
-864 Reduced 0.83%
103,331 $9.15 Million
Q3 2019

Nov 26, 2019

SELL
$62.98 - $75.72 $398,096 - $478,626
-6,321 Reduced 5.72%
104,195 $7.89 Million
Q2 2019

Aug 07, 2019

SELL
$65.7 - $83.98 $399,653 - $510,850
-6,083 Reduced 5.22%
110,516 $8.04 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $69,965 - $82,346
907 Added 0.78%
116,599 $9.4 Million
Q4 2018

Feb 05, 2019

SELL
$77.85 - $96.01 $535,296 - $660,164
-6,876 Reduced 5.61%
115,692 $10.7 Million
Q3 2018

Nov 08, 2018

BUY
$88.91 - $98.84 $143,589 - $159,626
1,615 Added 1.34%
122,568 $11.6 Million
Q2 2018

Aug 09, 2018

SELL
$89.78 - $106.23 $95,525 - $113,028
-1,064 Reduced 0.87%
120,953 $11.2 Million
Q1 2018

Aug 09, 2018

BUY
$92.01 - $123.21 $55,482 - $74,295
603 Added 0.5%
122,017 $11.5 Million
Q4 2017

Aug 09, 2018

BUY
$89.56 - $98.21 $10.9 Million - $11.9 Million
121,414
121,414 $11.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $337B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Redpoint Investment Management Pty LTD Portfolio

Follow Redpoint Investment Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.